Researchers develop human stem cell line containing sickle cell anemia mutation

Researchers at Johns Hopkins have established a human cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem cell like state. Researchers at Johns Hopkins have established a human cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem cell like state. Publishing online in Stem Cells on May 29, the team describes a faster and more efficient method of reprogramming cells that might speed the development of stem cell therapies.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news131291839.html">Researchers develop human stem cell line containing sickle cell anemia mutation</a></p> <p>Researchers at Johns Hopkins have established a human cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem cell like state. Researchers at Johns Hopkins have established a human cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem cell like state. Publishing online in <i>Stem Cells</i> on May 29, the team describes a faster and more efficient method of reprogramming cells that might speed the development of stem cell therapies.</p>